Advertisement

Brain Tumors, Intraocular and Orbital Tumors

  • Paul D. ChumasEmail author
  • Susan V. Picton
  • Ian Simmons
  • Manoj Parulekar
Chapter

Abstract

In children, brain and spinal cord tumors account for approximately 25 % of all cancer (40–50 % of all pediatric solid tumors). Overall, they are second only to the leukemias in frequency. There have been reports of an increasing incidence of both adult and pediatric brain tumors which may, in part, be due to “detection bias” although some epidemiology groups suggest that the increases are real. The annual incidence is approximately 2–5 cases per 100,000 (1 in 2500 children aged 0–16), which translates to approximately 300–400 new cases being diagnosed in the UK per year.

Keywords

Brain tumors Spinal cord tumors Intraoculcar tumors Orbital tumors 

References

  1. 1.
    Laurent JP, Cheek WR. Brain tumours in children. J Pediatr Neurosci. 1985;1:15–32.CrossRefGoogle Scholar
  2. 2.
    Allen JC. Childhood brain tumours: current status of clinical trials in newly diagnosed and recurrent disease. Pediatr Clin North Am. 1985;32:633–51.PubMedGoogle Scholar
  3. 3.
    McNally RJ, Kelsey AM, Cairns DP, et al. Temporal increases in the incidence of childhood solid tumours seen in Northwest England (1954–1998) are likely to be real. Cancer. 2001;92:1967–76.PubMedCrossRefGoogle Scholar
  4. 4.
    Parkin DM, Kramarova E, Draper GJ, et al. International incidence of childhood cancer. Lyon: IARC Sci Publ; 1998. p. 144.Google Scholar
  5. 5.
    Rorke LB. Introductory survey of brain tumours. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. 3rd ed. Philadelphia: WB Saunders Co; 1994. p. 351–5.Google Scholar
  6. 6.
    Bondy ML, Lustbader ED, Buffler PA, et al. Genetic epidemiology of childhood brain tumours. Genet Epidemiol. 1991;8:253–67.PubMedCrossRefGoogle Scholar
  7. 7.
    Draper G, Vincent T, Kroll ME, Swanson J. Childhood cancer in relation to distance from higher voltage power lines in England and Wales: a case-control study. BMJ. 2005;330:1290–3.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Biegel JA, Tan L, Zhang F, et al. Alterations of the hSNF5/InI1 gene in central nervous system atypical teratoid/rhabdoid tumours and renal and extrarenal rhabdoid tumours. Clin Cancer Res. 2002;8:3461–7.PubMedGoogle Scholar
  9. 9.
    Jenkins RB, Blair H, Ballman KV, et al. A t(1; 19) (q10; p10) mediates the combined deletions of 1p and 19q and predicts better prognosis of patients with oligodendroglioma. Cancer Res. 2006;66:9852–61.PubMedCrossRefGoogle Scholar
  10. 10.
    Stiller C. Population based survival rates for childhood cancer in Britain 1980–91. BMJ. 1994;309:1612–6.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Stupp R, et al. Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.PubMedCrossRefGoogle Scholar
  12. 12.
    Wesphal M, Hilt DC, Bortey E, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol. 2003;5:75–88.Google Scholar
  13. 13.
    Kibirige M, Birch J, Campbell R, et al. A review of astrocytoma in childhood. Pediatr Hematol Oncol. 1989;6(4):319–29.PubMedCrossRefGoogle Scholar
  14. 14.
    Greenberg MS. Handbook of neurosurgery. 3rd ed. Florida: Greenberg Graphics Inc; 1993. p. 686. 15. Huson S, Compston D, Harper P (1989) A genetic study of von Recklinghausen neurofibromatosis in South East Wales. II. Guidelines for genetic counseling. J Med Genet 26:712–721.Google Scholar
  15. 15.
    Schut L, Duhaime AC, Sutton LN. Phakomatoses: Surgical considerations. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. 3rd ed. Philadelphia: WB Saunders Co; 1994. p. 473–84.Google Scholar
  16. 16.
    Hope DG, Mulvihill JJ. Neurofibromatosis (von Recklinghausen’s Disease). Malignancy in neurofibromatosis. In: Riccardi VM, Mulvihill JJ, editors. Advances in neurology, vol. 29. New York: Raven; 1981. p. 35–6.Google Scholar
  17. 17.
    Chumas PD. Optic nerve glioma. In: Palmer JD, editor. Neurosurgery 96. Manual of neurosurgery. Edinburgh: Churchill Livingstone; 1996. p. 248–51.Google Scholar
  18. 18.
    Weichert K, Dire M, Benton C, et al. Macrocranium and neurofibromatosis. Radiology. 1973;107:163–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Sampson J, Scahill S, Stephenson J, et al. Genetic aspects of tuberous sclerosis in the West of Scotland. J Med Genet. 1989;26:28–31.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Martuza R. Neurofibromatosis and other phakomatoses. In: Wilkins R, Rengachary S, editors. Neurosurgery. New York: McGraw-Hill; 1982. p. 511–21.Google Scholar
  21. 21.
    Fitz C. Tuberous sclerosis. In: Hoffman HJ, Epstein F, editors. Disorders of the developing nervous system: diagnosis and treatment. Boston: Blackwell Scientific; 1986. p. 625–34.Google Scholar
  22. 22.
    Rorke LB, Schut L. Introductory survey of paediatric brain tumours. In: McLaurin RL et al., editors. Paediatric neurosurgery: surgery of the developing nervous system. 2nd ed. Philadelphia: WB Saunders Co; 1989. p. 335–7.Google Scholar
  23. 23.
    Illgren EB, Stiller CA. Cerebellar astrocytomas. Part I: macroscopic and microscopic features. Clin Neuropathol. 1987;6:185–200.Google Scholar
  24. 24.
    Garcia DM, Marks JE, Latifi HR, Kliefoth AB. Childhood cerebellar astrocytomas: is there a role for postoperative irradiation? Int J Radiat Oncol Biol Phys. 1990;18(4):815–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Garcia DM, Latifi HR, Simpson JR, Pickens S. Astrocytoma of the cerebellum in children. J Neurosurg. 1989;71:661–4.PubMedCrossRefGoogle Scholar
  26. 26.
    Undjian S, Marinov M, Georgieve K. Long-term follow-up after surgical treatment of cerebellar astrocytomas in 100 children. Childs Nerv Syst. 1989;5:99–101.PubMedCrossRefGoogle Scholar
  27. 27.
    Pagni CA, Giordama MT, Canarero S. Benign recurrence of a pilocytic cerebellar astrocytoma 36 years after radical removal: Case report. Neurosurgery. 1991;28:606–9.PubMedCrossRefGoogle Scholar
  28. 28.
    O’Brien MS, Krisht A. Cerebellar astrocytomas. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. Philadelphia: WB Saunders Co; 1994. p. 356–61.Google Scholar
  29. 29.
    Sutton LN, Packer RJ. Medulloblastomas. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. Philadelphia: WB Saunders Co; 1994. p. 362–73.Google Scholar
  30. 30.
    Ellison D. Classifying the medulloblastoma: insights from morphology and molecular genetic. Neuropathol Appl Neurobiol. 2002;28:257–82.PubMedCrossRefGoogle Scholar
  31. 31.
    Brown HG, Kepner JL, et al. Large cell/anaplastic medulloblastoma: a Pediatric Oncology Group study. J Neuropathol Exp Neurol. 2000;59:857–65.PubMedCrossRefGoogle Scholar
  32. 32.
    Gajjar A, Hernan R, et al. Clinical histopatholgic and molecular markers of prognosis: Towards a new disease risk stratification system for medulloblastoma. J Clin Oncol. 2004;22:984–93.PubMedCrossRefGoogle Scholar
  33. 33.
    Park T, Hoffman H, Hendrick E, et al. Medulloblastoma, clinical presentation and management. Experience at the Hospital for Sick Children, Toronto, 1950–1980. J Neurosurg. 1983;58:543–52.PubMedCrossRefGoogle Scholar
  34. 34.
    Packer RJ, Gajjar A, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24:4202–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Roman DD, Sperduto PW. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int J Radiat Oncol Biol Phys. 1995;31:983–98.PubMedCrossRefGoogle Scholar
  36. 36.
    Gerosa M, DiStefano E, Oliva A, et al. Multidisciplinary treatment of medulloblastoma. A 5-year experience with the SIOP trial. Childs Brain. 1981;8:107–18.PubMedGoogle Scholar
  37. 37.
    Rutkowski S, Bode U, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005;352:978–86.PubMedCrossRefGoogle Scholar
  38. 38.
    Prados MD, Edwards MS, et al. Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumours: results of phase II study. Int J Radiat Oncol Biol Phys. 1999;43:279–85.PubMedCrossRefGoogle Scholar
  39. 39.
    Duffner P, Cohen M, Anderson S, et al. Long-term effects of treatment on endocrine function in children with brain tumours. Ann Neurol. 1983;14:528–32.PubMedCrossRefGoogle Scholar
  40. 40.
    Ogilvy-Stuart AL, Shalet SM. Growth and puberty after growth hormone treatment after irradiation for brain tumours. Arch Dis Child. 1995;73:141–6.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Gentet JC, Doz F, et al. Carboplatin and VP 16 in medulloblastoma: a phase II study of the French Society of Paediatric Oncology (SFOP). Med Pediatr Oncol. 1994;23:422–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Lefkowitz IB, Packer RJ, et al. Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumours with lomustine, cisplatin and vincristine. Cancer. 1990;65:412–7.PubMedCrossRefGoogle Scholar
  43. 43.
    Taylor RE, Bailey CC, et al. Results of a randomisation study of preradiation chemotherapy versus radiotherapy alone for non-metastactic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children’s Cancer Study Group PNET-2 Study. J Clin Oncol. 2003;21:1581–91.PubMedCrossRefGoogle Scholar
  44. 44.
    Packer R, Sutton L, Goldwein J, et al. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg. 1991;74:433–40.PubMedCrossRefGoogle Scholar
  45. 45.
    Stiller CA, Allen MB, Eatock EM. Childhood cancer in Britain: The national registry of childhood tumours and incidence rates 1978–1987. Eur J Cancer. 1995;31A:2028–34.PubMedCrossRefGoogle Scholar
  46. 46.
    Tomita T, McLone DG, Das L, et al. Benign ependymomas of the posterior fossa in childhood. Pediatr Neurosci. 1988;14:277–85.PubMedCrossRefGoogle Scholar
  47. 47.
    Wisoff JH. Tumours of the cerebral hemispheres. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. Philadelphia: WB Saunders Co; 1994. p. 392–402.Google Scholar
  48. 48.
    Kleihues P, Bueger P, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol. 1993;3:255–68.PubMedCrossRefGoogle Scholar
  49. 49.
    Tomita T. Miscellaneous posterior fossa tumours. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. Philadelphia: WB Saunders Co; 1994. p. 383–91.Google Scholar
  50. 50.
    Pollack IF, Gerszten PC, Martinez AJ, et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery. 1995;37:655–67.PubMedCrossRefGoogle Scholar
  51. 51.
    Healey EA, Barnes PD, Kupsky WJ, et al. The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery. 1991;28:666–72.PubMedCrossRefGoogle Scholar
  52. 52.
    Ross GW, Rubinstein LJ. Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg. 1989;70:31–6.PubMedCrossRefGoogle Scholar
  53. 53.
    Jaing TH, Wang HS, et al. Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas. J Neurooncol. 2004;68:255–61.PubMedCrossRefGoogle Scholar
  54. 54.
    Geyer JR, Sposto R, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumours: a report from the Children’s Cancer Group. J Clin Oncol. 2005;23:7621–31.PubMedCrossRefGoogle Scholar
  55. 55.
    Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumours. N Engl J Med. 1993;328:1725–31.PubMedCrossRefGoogle Scholar
  56. 56.
    Abbott R, Ragheb J, Epstein FJ. Brainstem tumours: surgical indications. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. Philadelphia: WB Saunders Co; 1994. p. 374–82.Google Scholar
  57. 57.
    Kaplan AM, Albright AL, et al. Brainstem gliomas in children. A Children’s Cancer Group review of 119 cases. Pediatr Neurosurg. 1996;24:185–92.PubMedCrossRefGoogle Scholar
  58. 58.
    May PL, Blaser JI, Hoffman HJ, et al. Benign intrinsic tectal “tumours” in children. J Neurosurg. 1991;74:867–71.PubMedCrossRefGoogle Scholar
  59. 59.
    Hoffman HJ, Becker L, Craven MA. A clinically and pathologically distinct group of benign gliomas. Neurosurgery. 1980;7:243–8.PubMedCrossRefGoogle Scholar
  60. 60.
    Epstein FJ, Farmer JP. Brainstem glioma growth patterns. J Neurosurg. 1993;78:408–12.PubMedCrossRefGoogle Scholar
  61. 61.
    Dohrman GJ, Farwell JR, Flannery JT. Astrocytomas in childhood: a population based study. Surg Neurol. 1985;23:64–8.CrossRefGoogle Scholar
  62. 62.
    Jooma R, Hayward RD, Grant DN. Intracranial neoplasms during the first year of life: analysis of one hundred consecutive cases. Neurosurgery. 1984;14:31–41.PubMedCrossRefGoogle Scholar
  63. 63.
    Duffner PK, Cohen MD, Myers MH, et al. Survival of children with brain tumours. SEER Programme 1973–1980. Neurology. 1986;36:597–601.PubMedCrossRefGoogle Scholar
  64. 64.
    Palma L, Guidetti B. Cystic pilocytic astrocytomas of the cerebral hemispheres. Surgical experience with 51 cases and long-term results. J Neurosurg. 1985;62:811–5.PubMedCrossRefGoogle Scholar
  65. 65.
    Packer RJ, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low grade gliomas. J Neurosurg. 1997;86:747–54.PubMedCrossRefGoogle Scholar
  66. 66.
    Marchese MJ, Chang CH. Malignant astrocytic gliomas in children. Cancer. 1990;65:2771–8.PubMedCrossRefGoogle Scholar
  67. 67.
    Sposto R, Ertel IJ, Jenkin RDT, et al. The effectiveness of chemotherapy for the treatment of high-grade astrocytoma in children. Results of a randomized trial. J Neurooncol. 1989;7:165–77.PubMedCrossRefGoogle Scholar
  68. 68.
    Bower M, Newlands ES, et al. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol. 1997;40:484–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Brada M, Hoang ZK, et al. Multicentre phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol. 2001;2:259–66.CrossRefGoogle Scholar
  70. 70.
    Lashford LS, Thiesse P, et al. Temozolomide in malignant gliomas of childhood: a United Kingdom Children’s Cancer Study Group and French Society of Pediatric Oncology Intergroup study. J Clin Oncol. 2002;20:4684–91.PubMedCrossRefGoogle Scholar
  71. 71.
    Kun LE, Kovnar KH, Sanford RA. Ependymomas in children. Pediatr Neurosci. 1988;14:57–63.PubMedCrossRefGoogle Scholar
  72. 72.
    Nazar GB, Hoffman HJ, Becker LE, et al. Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg. 1990;72:408–17.PubMedCrossRefGoogle Scholar
  73. 73.
    Mork SJ, Lindegaard K-F, Halvorsen TN, et al. Oligodendroglioma: incidence and biological behaviour in a defined population. J Neurosurg. 1985;63:881–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Warnick RE, Edwards MSB. Paediatric brain tumours. Curr Probl Pediat. 1991;21:129–73.Google Scholar
  75. 75.
    Sutton LN, Packer J, Rorke LB, et al. Cerebral gangliogliomas during childhood. Neurosurgery. 1983;13:124–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Drake JM, Hendrick EB, Becker LE, et al. Intracranial meningiomasin children. Pediatr Neurosci. 1985–1986;12:134–9.Google Scholar
  77. 77.
    Johnson DL, McCullough DC. Optic nerve gliomas and other tumours involving the optic nerve and chiasm. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. 3rd ed. Philadelphia: WB Saunders Co; 1994. p. 409–17.Google Scholar
  78. 78.
    Barkovich AJ, Edwards M. CNS tumours. In: Barkovich AJ, editor. Paediatric neuroimaging. New York: Raven; 1990. p. 149–204.Google Scholar
  79. 79.
    Jenkins D, Angyalfi S, Becker L, Berry M, Runcie R, et al. Optic glioma in children: surveillance, resection, or irradiation. Int J Radiat Oncol Biol Phys. 1993;25:215–25.CrossRefGoogle Scholar
  80. 80.
    Hoffman HJ, Humphreys RP, Drake JM, Rutka JT, Becker LE, et al. Optic pathway/hypothalamic gliomas: a dilemma in management. Pediatr Neurosurg. 1993;19:186–95.PubMedCrossRefGoogle Scholar
  81. 81.
    Kestle JR, Hoffman HJ, Mock AR. Moyamoya phenomenon after radiation for optic glioma. J Neurosurg. 1993;79:32–5.PubMedCrossRefGoogle Scholar
  82. 82.
    Petronio J, Edwards MS, Prados M, Freyberger S, Rabbitt J, et al. Management of chiasmal and hypothalamic gliomas of infancy and childhood with chemotherapy. J Neurosurg. 1991;74:701–8.PubMedCrossRefGoogle Scholar
  83. 83.
    Moghrabi A, Friedman HS, Burger PC, et al. Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy. J Neurosurg. 1993;79:223–7.PubMedCrossRefGoogle Scholar
  84. 84.
    Hoffman HJ, Kestle JRW. Craniopharyngiomas. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. 3rd ed. Philadelphia: WB Saunders Co; 1994. p. 418–28.Google Scholar
  85. 85.
    Várady P. Craniopharyngioma. In: Palmer JD, editor. Neurosurgery 96. Manual of neurosurgery. Edinburgh: Chuchill Livingstone; 1996. p. 257–63.Google Scholar
  86. 86.
    Szeifert GT, Sipos L, Horváth M, Sarker MH, Major O, et al. Pathological characteristics of surgically removed craniopharyngiomas. Analysis of 131 cases. Acta Neurochir (Wien). 1993;124:139–43.CrossRefGoogle Scholar
  87. 87.
    Hoffman HJ, da Silva M, Humphreys RP, et al. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg. 1992;76:47–52.PubMedCrossRefGoogle Scholar
  88. 88.
    DeVile CJ, Grant DB, Kendall BE, Neville BGR, Stanhope R, et al. Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg. 1996;85:73–81.CrossRefGoogle Scholar
  89. 89.
    Takahashi H, Nakazawa S, Shimura I. Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children. J Neurosurg. 1985;62:120–7.PubMedCrossRefGoogle Scholar
  90. 90.
    Edwards MSB, Baugmartner JE. Pineal region tumours. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. 3rd ed. Philadelphia: WB Saunders Co; 1994. p. 429–36.Google Scholar
  91. 91.
    Hoffman HJ, Yoshida M, Becker LE, et al. Experience with pineal region tumours in childhood. Experiences at the Hospital for Sick Children. In: Humphreys RP, editor. Concepts in paediatric neurosurgery, vol. 4. Basel: Karger; 1983. p. 360–86.Google Scholar
  92. 92.
    Tien RD, Barkovich AF, Edwards MSB. MR imaging of pineal tumours. Am J Neuroradiol. 1990;II:557.Google Scholar
  93. 93.
    Dearnaly DP, O’Hern RP, Whittaker S, et al. Pineal and CNS germ cell tumours: Royal Marsden Hospital experience 1962–1987. Int J Radiat Oncol Biol Phys. 1990;18:773.CrossRefGoogle Scholar
  94. 94.
    Abay EO, Laws ER, Grado GL, et al. Pineal tumours in children and adolescents: treatment by shunting and radiotherapy. J Neurosurg. 1981;55:889–95.PubMedCrossRefGoogle Scholar
  95. 95.
    Edwards MSB, Hudgins RJ, Wilson CB. Pineal region tumours in children. J Neurosurg. 1988;68:689–97.PubMedCrossRefGoogle Scholar
  96. 96.
    Regis J, Bouillot P, Rouby-Volot F, et al. Pineal region tumours and the role of stereotactic biopsy: review of the mortality, morbidity and diagnostic rates in 370 cases. Neurosurgery. 1996;39:907–14.PubMedGoogle Scholar
  97. 97.
    Ho DM, Wong T, Liu H. Choroid plexus tumours in childhood: histopathologic study and clinico-pathological correlation. Childs Nerv Syst. 1991;7:437–41.PubMedCrossRefGoogle Scholar
  98. 98.
    Coates TL, Hinshaw DB, Peckman N. Paediatric choroid plexus neoplasm: MR, CT, and pathologic correlation. Radiology. 1989;173:81–8.PubMedCrossRefGoogle Scholar
  99. 99.
    Sanford RA, Donahue DJ. Intraventricular tumours. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. 3rd ed. Philadelphia: WB Saunders Co; 1994. p. 403–8.Google Scholar
  100. 100.
    Pillay PK, Humphreys RP, St Clair S, et al. Choroid plexus carcinomas in children: a role for preresection chemotherapy. AANS Annual Meeting Programme. 1992;484:(abstr).Google Scholar
  101. 101.
    Park TS, Kaufman BA. Tumours of the skull and metastatic brain tumours. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. 3rd ed. Philadelphia: WB Saunders Co; 1994. p. 437–45.Google Scholar
  102. 102.
    Ruge JR, Tomita T, Naidich TP, et al. Scalp and calvarial masses of infants and children. Neurosurgery. 1988;22:1037–42.PubMedCrossRefGoogle Scholar
  103. 103.
    Matsumoto J, Towbin RB, Ball WS. Craniofacial chordomas in infancy and childhood. A report of two cases and review of the literature. Pediatr Radiol. 1989;20:28.PubMedCrossRefGoogle Scholar
  104. 104.
    Di Lorenzo N, Giuffre R, Fortuna A. Primary spinal neoplasms in childhood: analysis by 1234 published cases (including 56 personal cases) by pathology, sex, age and site. Differences from the situation in adults. Neurochirurgia. 1982;25:153–64.PubMedGoogle Scholar
  105. 105.
    Batnitzky S, Keucher TR, Mealey Jr J, et al. Iatrogenic intraspinal epidermoid tumours. JAMA. 1977;237:148–50.PubMedCrossRefGoogle Scholar
  106. 106.
    Coulon RA. Extramedullary spinal tumours. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. 3rd ed. Philadelphia: WB Saunders Co; 1994. p. 458–72.Google Scholar
  107. 107.
    McElwain TJ, Clink HM, Jameson B, et al. Central nervous system involvement in acute myelogenous leukaemia. In: Whitehouse JMA, Kay HE, editors. Central nervous system complications of malignant disease. London: Macmillan; 1979. p. 91–6.CrossRefGoogle Scholar
  108. 108.
    Epstein FJ, Ragheb J. Intramedullary tumours of the spinal cord. In: Marlin AE, McLone DG, Reigel DH, Walker ML, editors. Paediatric neurosurgery. 3rd ed. Philadelphia: WB Saunders Co; 1994. p. 446–57.Google Scholar
  109. 109.
    Sanders BM, Draper GJ, Kingston JC. Retinoblastoma in Great Britain 1969–1980: incidence, treatment and survival. Br J Ophthalmol. 1983;72:576–83.CrossRefGoogle Scholar
  110. 110.
    Rodriguez-Galindo C, Wilson MW, Chantada G, Fu L, Qaddoumi I, Antoneli C, Leal Leal C, Sharma T, Barnoya M, Epelman S, Pizzarello L, Kane JR, Barfield R, Merchant TE, Robison LL, Murphree AL, Chevez-Barrios P, Dyer MA, O'Brien J, Ribeiro RC, Hungerford J, Helveston EM, Haik BG, Wilimas J. Retinoblastoma: one world, one vision. Pediatrics. 2008;122(3):e763–70.PubMedPubMedCentralCrossRefGoogle Scholar
  111. 111.
    Corson TW, Gallie BL. One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosom Cancer. 2007;46(7):617–34.PubMedCrossRefGoogle Scholar
  112. 112.
    Shields JA, Shields CL, Parsons HM. Differential diagnosis of retinoblastoma. Retina. 1991;11(2):232–43.PubMedCrossRefGoogle Scholar
  113. 113.
    Chan HS, Gallie BL, Munier FL, Beck Popovic M. Chemotherapy for retinoblastoma. Ophthalmol Clin North Am. 2005;18(1):55–63.PubMedCrossRefGoogle Scholar
  114. 114.
    Munier FL, Gaillard MC, Balmer A, Soliman S, Podilsky G, Moulin AP, Beck-Popovic M. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications. Br J Ophthalmol. 2012;96(8):1078–83.PubMedCrossRefGoogle Scholar
  115. 115.
    MacCarthy A, Bayne AM, Draper GJ, Eatock EM, Kroll ME, Stiller CA, Vincent TJ, Hawkins MM, Jenkinson HC, Kingston JE, Neale R, Murphy MF. Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol. 2009;93(9):1159–62.PubMedCrossRefGoogle Scholar
  116. 116.
    Antonelli C, Steinhorst F, Ribeiro K, et al. Extraocular retinoblastoma: a 13-year experience. Cancer. 2003;98:1292–8.CrossRefGoogle Scholar
  117. 117.
    Stevenson KE, Hungeford JL, Garner A. Local extension of retinoblastoma following intraocular surgery. Br J Ophthalmol. 1989;73:739–42.PubMedPubMedCentralCrossRefGoogle Scholar
  118. 118.
    Canning R, McCartney ACE, Hungerford JL. Medulloepithelioma (diktyoma). Br J Ophthalmol. 1988;72:764–7.PubMedPubMedCentralCrossRefGoogle Scholar
  119. 119.
    Shields JA, Shields CL. Intraocular tumours: a text and atlas. Philadelphia: WB Saunders Co; 1992. p. 320–32.Google Scholar
  120. 120.
    Zimmerman LE, Brougthton WL. A clinicopathologic and follow up study of fifty-six cases of intraocular medulloepithelioms. In: Jakobiec FA, editor. Ocular and adnexal tumours. Birmingham: Aesculapius; 1978. p. 181–96.Google Scholar
  121. 121.
    Jumper MJ, Char DH, Howes EL, Bitner DG. Neglected malignant medulloepithelioma of the eye. Orbit. 1999;18:37–43.PubMedCrossRefGoogle Scholar
  122. 122.
    Ayres B, Brasil OM, Klymberg C, et al. Ciliary body medulloepithelioma: clinical, ultrasound biomicroscopic and histopathological correlation. Graefes Arch Clin Exp Ophthalmol. 2006;34:695–8.CrossRefGoogle Scholar
  123. 123.
    Davidorf FH, Craig E, Birnbaum L, Wakely P. Management of medulloepithelioma of the ciliary body with brachytherapy. Am J Ophthalmol. 2002;133:841–3.PubMedCrossRefGoogle Scholar
  124. 124.
    Shields CL, Shields JA, Milite J, et al. Uveal melanomas in teenagers and children. A report of 40 cases. Ophthalmology. 1991;98:1662–6.PubMedCrossRefGoogle Scholar
  125. 125.
    Palazzi MA, Ober MD, Abreu HF. Congenital uveal malignant melanoma: a case report. Can J Ophthalmol. 2005;40:611–5.Google Scholar
  126. 126.
    Neurofibromatosis. Conference statement.National Institutes of Health Consensus Development Conference. Arch Neurol Chicago. 1998;45:575–8.Google Scholar
  127. 127.
    Daston MM, Scrable H, Nordlund M, et al. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes. Neuron. 1992;8:415–28.PubMedCrossRefGoogle Scholar
  128. 128.
    Listernick R, Louis DN, Packer J, et al. Optic pathway gliomas in children with neurofibromatosis type 1: Consensus statement from the NF1 optic pathway glioma study. J Paediatr Child Health. 1994;125:63–6.Google Scholar
  129. 129.
    Sharif S, Ferner R, Birch JM, et al. Second primary tumours in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol. 2006;24:2570–5.PubMedCrossRefGoogle Scholar
  130. 130.
    Listermick R, Darling C, Greenwald M, et al. Optic pathway tumours in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr. 1995;127:718–22.CrossRefGoogle Scholar
  131. 131.
    Krueger DA, Care MM, Katherine H, Karen A, Cynthia T, Prajakta M, Wilson KA, Anna B, Tarek S, David Neal F. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010;363:1801–11.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Paul D. Chumas
    • 1
    Email author
  • Susan V. Picton
    • 2
  • Ian Simmons
    • 3
  • Manoj Parulekar
    • 4
  1. 1.Department of NeurosurgeryLeeds General InfirmaryLeedsEngland, UK
  2. 2.Childrens Oncology and HaematologyChildrens HospitalLeedsEngland, UK
  3. 3.Paediatric OphthalmologySpire Leeds HospitalLeedsEngland, UK
  4. 4.Ophthalmic SurgeryBirmingham Children’s HospitalBirminghamEngland, UK

Personalised recommendations